Skip to content
DraconiticResearch
Search Sources API
189,280 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYBiomedicines

A Synbiotic for the Oral–Nasal Gateway: The Mechanistic Rationale, Pathogen-Targeting Profile, and Implications for Gut and Pulmonary Health

  • John N. Peldyak1
  • Paul Reynolds2
  • César Alas Pineda3
  • Gustavo Ferrer4
  • Mark L. Cannon5
5 affiliations
  1. 1Independent Researcher, Mount Pleasant, MI 48858, USA
  2. 2Department of Cell Biology and Physiology, , Provo, UT 84602, USA
  3. 3Department of Research and Development, Moxie Health Group, Hallandale Beach, FL 33008, USA;
  4. 4Pulmonary and Critical Care Medicine, , Aventura, FL 33180, USA;
  5. 5Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Read full textPDFCite

Related

  1. Structural and immunogenic characterisation of ChAdOx1 Chik-derived Chikungunya VLPs supports a mechanistic rationale for vaccine-induced protection
    Young Chan Kim, Xiyong Song, Yasunori Watanabe +9
    npj VirusesPeer-reviewedCC BYFull textEpidemiology & public healthDOAJ
  2. Astaxanthin and Related Carotenoids as a Dual Modulator of Nrf2 and NF-κB in Bisretinoid-Induced Retinal Damage: Mechanistic Rationale and Evidence Gaps.
    Babita Kumari Baniya, Hye Jin Kim
    Antioxidants (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. SGLT2 inhibitors and exercise in diabetic kidney disease: mechanistic rationale, emerging clinical evidence, and future perspectives.
    Huajuan Li, Min Ai, Xiangyu He +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Advances in Somatostatin Receptor-Targeting Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Biological Rationale, Combination Strategies, and Clinical Perspectives.
    Hana Bakr, Amin Al-Awar, Johan K E Spetz +1
    International journal of molecular sciencesPeer-reviewedCC BYFull text1 citedEpidemiology & public healthEurope PMC
  5. Checkpoint-checkpoint combinations in cancer: from mechanistic rationale to translational impact.
    Alessandro Mazzocca, Silvia Calagna, Emanuele Claudio Mingo +9
    Journal of translational medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{peldyak2026synbiotic,
  title = {{A Synbiotic for the Oral–Nasal Gateway: The Mechanistic Rationale, Pathogen-Targeting Profile, and Implications for Gut and Pulmonary Health}},
  author = {John N. Peldyak and Paul Reynolds and César Alas Pineda and Gustavo Ferrer and Mark L. Cannon},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13701600},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - A Synbiotic for the Oral–Nasal Gateway: The Mechanistic Rationale, Pathogen-Targeting Profile, and Implications for Gut and Pulmonary Health
AU  - John N. Peldyak
AU  - Paul Reynolds
AU  - César Alas Pineda
AU  - Gustavo Ferrer
AU  - Mark L. Cannon
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701600
SN  - 2227-9059
ER  -